Serina Therapeutics (SER) Return on Sales (2018 - 2026)
Serina Therapeutics (SER) posted Return on Sales of 1.93% for Q4 2025, up 9.06% sequentially from 2.12% in Q3 2025, and down 615.0% YoY from 0.37% in Q4 2024.
Serina Therapeutics (SER) Return on Sales (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Return on Sales for 8 years, with the latest figure at 1.93% in Q4 2025.
- Quarterly Return on Sales fell 615.0% year-over-year to 1.93% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.93% (up 144.0% YoY) and the FY2025 annual result came in at 1.48%, up 52.0% from the prior year.
- Return on Sales climbed to 1.93% in Q4 2025 per SER's latest filing, from 2.12% in the prior quarter.
- Over five years, Return on Sales peaked at 4.22% in Q4 2024 and troughed at 6.01% in Q1 2024.
- A 5-year average of 1.52% and a median of 1.19% in 2024 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2023 and 2025: Return on Sales jumped 506 bps in 2023, then plunged 615 bps in 2025.
- Over 5 years, Return on Sales stood at 0.0% in 2021, then plunged by 59805 bps to 2.23% in 2022, then surged by 100 bps to 0.0% in 2023, then soared by 299425 bps to 4.22% in 2024, then plunged by 146 bps to 1.93% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 1.93%, 2.12%, and 0.46% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 0.00% |
| 10 | Serina Therapeutics | 43.42 Mn | 20.40 Mn | - | -1.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.13% |
| Dec 31, 2025 | -1.93% |
| Sep 30, 2025 | -2.12% |
| Jun 30, 2025 | -0.46% |
| Mar 31, 2025 | -4.34% |
| Dec 31, 2024 | 4.22% |
| Sep 30, 2024 | -3.88% |
| Jun 30, 2024 | -0.88% |
| Mar 31, 2024 | -6.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.54% |
| Jun 30, 2023 | -1.50% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | -2.23% |
| Sep 30, 2022 | -2.71% |
| Jun 30, 2022 | -2.18% |
| Mar 31, 2022 | -5.41% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |